Humacyte, Inc. (NASDAQ:HUMA) Shares Bought by Rhumbline Advisers
Rhumbline Advisers grew its position in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 4.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 114,455 shares of the company’s stock after purchasing an additional 5,005 shares during the quarter. Rhumbline Advisers’ holdings in Humacyte […]
